.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing burn injuries in the elderly is a significant clinical challenge for surgeons and geriatricians worldwide. Cellular senescence in burns has recently emerged as a primary factor behind delayed wound healing and poor prognostic outcomes. A new study using aged murine models provides compelling evidence that senolytic therapies could transform the management of thermal injuries in older adults.
Cellular senescence in burns leads to the accumulation of damaged cells that effectively block tissue regeneration. Researchers investigated this role using a full-thickness scald burn model. They found that aged mice exhibited significantly higher levels of SA-β-Gal-positive skin cells after injury. These senescent cells were associated with a decrease in myofibroblast activity and an increase in extracellular matrix-degrading components. Consequently, older subjects experienced prolonged healing times compared to younger controls.
The investigation utilized a senolytic combination of Dasatinib and Quercetin to target and clear these dysfunctional cells. This treatment effectively reduced cellular senescence in burn wounds by over four times, bringing markers back toward baseline levels. Furthermore, the therapy successfully restored the expression of critical healing markers such as α-SMA and Col1a1. As a result, the macroscopic healing of burn wounds in the aged mice improved dramatically. Moreover, this approach specifically addresses the biological causes of age-related healing deficits rather than just treating the symptoms.
In India, the elderly population is growing rapidly, which increases the burden on specialized burn units. These findings suggest that senescence-targeting therapies could eventually become a vital part of geriatric clinical protocols. By addressing the underlying cellular senescence in burns, healthcare providers may improve survival rates and reduce the long-term morbidity associated with slow-healing wounds. However, clinicians must wait for human clinical trials to confirm these promising results from animal models.
Senolytics are a class of drugs, such as Dasatinib and Quercetin, designed to selectively eliminate senescent cells. In burn care, these drugs help clear the \"zombie cells\" that prevent proper skin repair, thereby accelerating the healing process in older patients.
Cellular senescence in burns causes cells to enter a state of permanent growth arrest. These cells release harmful inflammatory factors that degrade the skin's structural integrity and inhibit the essential work of healing cells like fibroblasts.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Faour S et al. Targeting Cellular Senescence Enhances Post-Burn Wound Healing in Aged Mice. Shock. 2026 Jun 22. doi: 10.1097/SHK.0000000000002898. PMID: 42320016.
Chia JJ et al. Cellular senescence and wound healing in aged and diabetic skin. Frontiers in Physiology. 2024 Feb 18;15:1350101.
Kumar A et al. Geriatric Burn Care, Challenges and Opportunities in a Tertiary Care Centre in North India. Indian Journal of Community Health. 2026 May.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Older burn patients face high mortality and delayed healing. This new study in aged mice reveals that targeting cellular senescence with senolytics—specifically Dasatinib and Quercetin—reduces skin cell senescence and improves macroscopic healing outcomes, offering a potential strategy for geriatric care.
last month
Researchers at Kyushu University have uncovered a novel compound, lipoic acid trisulfide (LASSS), that enhances hepatocyte growth factor (HGF) signaling and protects against nitration-induced protein dysfunction, presenting a potential breakthrough for age-related muscle atrophy and sarcopenia.
Yesterday
A study identifies a critical hypospadias gene-environment interaction. Research shows that the risk gene DNAH8 and DEHP exposure combine to disrupt steroidogenesis and mesenchymal progenitor cell differentiation, significantly increasing the risk of severe urethral malformations in male fetuses.
5 days back
A pre-clinical study reveals that elevated serum pro-N-cadherin levels correlate strongly with severe cardiac fibrosis and diastolic dysfunction following radiation exposure, promising a potential early biomarker for radiation-related heart disease.
3 days back
Discover how biophysical forces shape tissue formation and regeneration. This review explores mechanotransduction in tissue development, from molecular sensors like integrins to tissue-scale flows, highlighting critical implications for regenerative medicine and functional organoid engineering.
Last week
A groundbreaking study utilizes single-cell RNA sequencing to map the tumor microenvironment of ovarian steroid cell tumors-not otherwise specified (SCT-NOS), identifying key steroidogenic subtypes and immune cell distributions that drive hyperandrogenism and tumor progression.
Last week
